ABL Bio

본문영역 바로가기

Investors & Media

News

HomeInvestors & MediaNews

[조선비즈] [K바이오리더] 이상훈 에이비엘바이오 대표 “연구개발에 헛돈 쓴다고 했지만 파킨슨병 치료제로 1兆 잭팟”: 2022-02-13ablbio; https://biz.chosun.com/it-science/bio-science/2022/02/13/HXIJSOSMJBHHJA22FWVV7TMWUY/?utm_source=naver&utm_medium=original&utm_campaign=biz

list

PREV: ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson’s Disease

NEXT